A new experimental drug shows promise for severe fatty liver disease. This compound targets the gut, not the liver directly. It repairs a damaged intestinal barrier, reducing toxins reaching the liver. This discovery offers a fresh treatment path for a widespread condition. Human trials are needed to confirm its safety and effectiveness.